최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기大韓癌韓醫學會誌 = Journal of Korean traditional oncology, v.20 no.1, 2015년, pp.31 - 44
이지영 (강동경희대학교병원 한방암센터 한방내과) , 오혜경 (강동경희대학교병원 한방암센터 한방내과) , 류한성 (강동경희대학교병원 한방암센터 한방내과) , 윤성우 (강동경희대학교병원 한방암센터 한방내과)
Background : The purpose of this study is to investigate the efficacy and safety of the circadian delivery schedule of fluorouracil or capecitabine based chemotherapy for advanced colorectal cancer. Patients and methods : A meta-analysis was performed using individual data from eight international r...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Greene MW, Circadian rhythms and tumor growth, Cancer letters 2012;318:115-23.
Takeda N, Maemura K, Circiadian clock and cardiovascular disease, J Cardiol 2011;57(3):249-56.
Bonny O, Firsov D, Circadian regulation of renal function and potential role in hypertension, Curr Opin Nephrol Hypertens 2013;22(4):439-44.
Durrington HJ, Farrow SN, Loudon AS, Ray DW, The circadian clock and asthma, Thorax 2014;69(1):90-2.
G?mez-Abell?n P, Madrid JA, Ordov?s JM, Garaulet M. Chronobiological aspects of obesity and metabolic syndrome, Endocrinol Nutr 2012;59(1):50-61.
Innominato PF, Levi FA, Bjarnason GA, Chronotherapy and the molecular clock: Clinical implications in oncology, Adv drug deliv rev 2010;62:979-1001.
Savvidis C, Koutsilieris M, Circadian rhythm disruption in cancer biology, Mol Med 2012;18:1249-60.
Mormont MC, Levi F, Circadian-system alterations during cancer processes: a review. Int J Cancer 1997;70(2):241-7.
Blask DE, Dauchy RT, Dauchy EM, Mao L, Hill SM, Greene MW, et al. Light exposure at night disrupts host/cancer circadian regulatory dynamics: impact on the Warburg effect, lipid signaling and tumor growth prevention, PLoS One 2014;9(8):e102776.
Tilma Vistisen H, Helene Garde A, Marie Hansen A, Hansen J, Christiansen P, Kolstad H, 0222 night work and breast cancer risk among women in the public Danish health care sector ? a short-term follow up of a large scale population. Occup Environ Med 2014;71(1):A30.
Papantoniou K, Kogevinas M, Martin Sanchez V, Moreno V, Pollan M, Moleon JJ, 0058 Colorectal cancer risk and shift work in a population-based case-control study in Spain (MCC-Spain). Occup Environ Med 2014;71(1):A5-6.
Eriguchi M, Levi F, Hisa T, Yanagie H, Nonaka Y, Takeda Y, Chronotherapy for cancer, Biomedicine & Pharmaco, 2003;57:92-5.
Levi F, Focan C, Karaboue A, de la Valette V, Focan-Henrard D, Baron B, et al. Implications of circadian clocks for the rhythmic delivery of cancer therapeutics, Adv Drug Deliv Rev 2007;59(9-10):1015-35.
안창범, 이윤호, 자오유주침법에 대한 문헌적 고찰, 대한침구학회지 1986;3:61-82.
황현서, 김기현, 박동석, 자오유주납갑법에 관한 고찰, 대한침구학회지 1997;14(1):155-64.
Levi FA, Zidani R, Vannetzel JM, Perpoint B, Focan C, Faggiuolo R, et al. Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial, J Natl Cancer Inst 1994;86(21):1608-17.
Levi F, Zidani R, Misset JL, Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer, Lancet 1997;350:681-6.
Thrall MM, Wood P, King V, Rivera W, Hrushesky W, Investigation of the comparative toxicity of 5-FU bolus versus 5-FU continuous infusion circadian chemotherapy with concurrent radiation therapy in locally advanced rectal cancer, Int J Radiation Oncology Biol Phys 2000;46(4):873-81.
Price TJ, Ross PJ, Hickish T, Tait D, Norman AR, Ford HER, et al. Phase III study of mitomycin-C with protracted venous infusion or circadian-timed infusion of 5-fluorouracil in advanced colorectal carcinoma, Clin Colorectal Cancer 2004;3(4):235-42.
Garufi C, Vanni B, Aschelter AM, Zappala AR, Bria E, Nistico C, et al. Randomized phase II study of standard versus chronomodulated CPT-11 plus chronomodulated 5-fluorouracil and folinic acid in advanced colorectal cancer patients, Euro J Cancer 2005;42:608-16.
Giacchetti S, Bjarnason G, Garufi C, Genet D, Iacobelli S, Tampellii M, et al. Phase III trial comparind 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the european organisation for research and treatment of cancer chronotherapy group, J Clin Oncol 2006;24(22):3562-9.
Ramanathan RK, Bjarnason GA, Bernard SA, Desimone P, Braich T, Evers JP, et al. A four-arm, randomized, multicenter phase II trial of oxaliplatin combined with varying schedules of 5-fluorouracil as first-line therapy in previously untreated advanced colorectal cancer, Clin Colorectal Cancer, 2008;7(2):134-9.
Qvortrup C, Jensen BV, Fokstuen T, Nielsen SE, Keldsen N, Glimelius B, et al. A randomized study comparing short-time infusion of oxaliplatin in combination with capecitabine XELOX30 and chronomodulated XELOX30 as first-line therapy in patients with advanced colorectal cancer, Ann of Oncol 2010;21:87-91.
Liao C, Li J, Bin Q, Cao Y, Gao F, Chronomodulated chemotherapy versus conventional chemotherapy for advanced colorectal cancer: a meta-analysis of five randomized controlled trials, Int J Colorectal Dis 2010;25:343-50.
Giacchetti S, Dugue PA, Innominato PF, Bjarnason GA, Focan C, Garufi C, et al. Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis, Annals of Oncology 2012;23:3110-6.
Seki K, Chisaka M, Eriguchi M, Yanagie H, Hisa T, Osada I, et al. An attempt to integrate western and chinese medicine: rationale for applying chinese medicine as chronotherapy against cancer, Biomed Pharmacother 2005;59(1):S132-40.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.